Google Behind Deep Learning Tool To Search Out Diseases

Alphabet’s Verily has developed a new machine learning approach for mass spectrometry that can interpret data and identify new disease biomarkers. Aptly named DeepMass, the method has shown to be more accurate in early tests than an existing predictive model and also enlarged the scope of known biomarkers when applied to clinical data...